Floatz logo

Camustine

Hodgkins Lymphoma

VIVUS LLCSmall moleculePhase 2Active
BBB
74/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
61/ 100
Competitive Position
95/ 100

Competitive context

140 Active assets in the Hodgkins Lymphoma cohort.

Asset / SponsorPhaseRating
Methotrexate
Therapeutic Advances in Childhood Leukemia Consortium
Phase 3BBB
Carboplatin
St. Petersburg State Pavlov Medical University
Phase 2BBB
Everolimus
OHSU Knight Cancer Institute
Phase 2BBB
Isocyclophosphamide
St. Petersburg State Pavlov Medical University
Phase 3BBB
Cyclosporin A
City of Hope Medical Center
Phase 3BBB

View all 50 →

Same molecule, other indications

Camustine is also rated in:

B-cell non-Hodgkin lymphomaActive
BBB
Indicative · Phase 4
73 / 100
View asset →
central nervous system neoplasmDormant
BBB
Indicative · Phase 3
72 / 100
View asset →
Burkitt lymphomaActive
BB
Indicative · Phase 4
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →